An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
Stopped Low Recruitment
Conditions
- Lung Cancer
- Non-small Cell Lung Cancer
Sponsor
AstraZeneca